Time-varying mHAP III is the most accurate score in predicting survival in patients with hepatocellular carcinoma (HCC) undergoing trans-arterial chemoembolization (TACE). (February 2019) - Campani, C.; Vitale, A.; Dragoni, G.; Aburas, S.; Arena, U.; Laffi, G.; Cillo, U.; Giannini, E.G.; Trevisani, F.; Marra, F.; ,